Published in Cardiovascular Week, October 23rd, 2006
"Quantitative markers of Alzheimer disease (AD), particularly in the early stages, are needed for clinical assessment and monitoring. We have evaluated a novel method to segment and visualize the ventricular system and obtain volumetric measures thereof," wrote F.L. Giesel and colleagues of the Deutsch Krebsforschungszentrum.
"The temporal horn volume (THV) and index in patients with mild cognitive impairment (MCI) and in those with AD were evaluated. High-resolution...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.